The former starts with a downregulation of allostatic genes, such as the above-mentioned TMEM119, P2RY12, and CX3CR1, along with an augmented expression rate of AD-related ones, for instance, APOE, CTSB, and CTSD. This evidence concerns the gene APOE and Alzheimer disease.